Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma
The measurement of exhaled volatile organic compounds (VOCs) in exhaled breath (breathomics) represents an exciting biomarker matrix for airways disease, with early research indicating a sensitivity to airway inflammation. One of the key aspects to analytical validity for any clinical biomarker is a...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/10/1635 |
_version_ | 1797472271475933184 |
---|---|
author | Adnan Azim Faisal I. Rezwan Clair Barber Matthew Harvey Ramesh J. Kurukulaaratchy John W. Holloway Peter H. Howarth |
author_facet | Adnan Azim Faisal I. Rezwan Clair Barber Matthew Harvey Ramesh J. Kurukulaaratchy John W. Holloway Peter H. Howarth |
author_sort | Adnan Azim |
collection | DOAJ |
description | The measurement of exhaled volatile organic compounds (VOCs) in exhaled breath (breathomics) represents an exciting biomarker matrix for airways disease, with early research indicating a sensitivity to airway inflammation. One of the key aspects to analytical validity for any clinical biomarker is an understanding of the short-term repeatability of measures. We collected exhaled breath samples on 5 consecutive days in 14 subjects with severe asthma who had undergone extensive clinical characterisation. Principal component analysis on VOC abundance across all breath samples revealed no variance due to the day of sampling. Samples from the same patients clustered together and there was some separation according to T2 inflammatory markers. The intra-subject and between-subject variability of each VOC was calculated across the 70 samples and identified 30.35% of VOCs to be erratic: variable between subjects but also variable in the same subject. Exclusion of these erratic VOCs from machine learning approaches revealed no apparent loss of structure to the underlying data or loss of relationship with salient clinical characteristics. Moreover, cluster evaluation by the silhouette coefficient indicates more distinct clustering. We are able to describe the short-term repeatability of breath samples in a severe asthma population and corroborate its sensitivity to airway inflammation. We also describe a novel variance-based feature selection tool that, when applied to larger clinical studies, could improve machine learning model predictions. |
first_indexed | 2024-03-09T19:59:31Z |
format | Article |
id | doaj.art-f1eac78313594a2088429a22b8079748 |
institution | Directory Open Access Journal |
issn | 2075-4426 |
language | English |
last_indexed | 2024-03-09T19:59:31Z |
publishDate | 2022-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Personalized Medicine |
spelling | doaj.art-f1eac78313594a2088429a22b80797482023-11-24T00:49:36ZengMDPI AGJournal of Personalized Medicine2075-44262022-10-011210163510.3390/jpm12101635Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe AsthmaAdnan Azim0Faisal I. Rezwan1Clair Barber2Matthew Harvey3Ramesh J. Kurukulaaratchy4John W. Holloway5Peter H. Howarth6Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UKDepartment of Computer Science, Aberystwyth University, Aberystwyth SY23 3DB, UKClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UKNIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton SO16 6YD, UKClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UKNIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton SO16 6YD, UKClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UKThe measurement of exhaled volatile organic compounds (VOCs) in exhaled breath (breathomics) represents an exciting biomarker matrix for airways disease, with early research indicating a sensitivity to airway inflammation. One of the key aspects to analytical validity for any clinical biomarker is an understanding of the short-term repeatability of measures. We collected exhaled breath samples on 5 consecutive days in 14 subjects with severe asthma who had undergone extensive clinical characterisation. Principal component analysis on VOC abundance across all breath samples revealed no variance due to the day of sampling. Samples from the same patients clustered together and there was some separation according to T2 inflammatory markers. The intra-subject and between-subject variability of each VOC was calculated across the 70 samples and identified 30.35% of VOCs to be erratic: variable between subjects but also variable in the same subject. Exclusion of these erratic VOCs from machine learning approaches revealed no apparent loss of structure to the underlying data or loss of relationship with salient clinical characteristics. Moreover, cluster evaluation by the silhouette coefficient indicates more distinct clustering. We are able to describe the short-term repeatability of breath samples in a severe asthma population and corroborate its sensitivity to airway inflammation. We also describe a novel variance-based feature selection tool that, when applied to larger clinical studies, could improve machine learning model predictions.https://www.mdpi.com/2075-4426/12/10/1635breathomicsVOCvolatile organic compoundsrepeatabilityasthmasevere asthma |
spellingShingle | Adnan Azim Faisal I. Rezwan Clair Barber Matthew Harvey Ramesh J. Kurukulaaratchy John W. Holloway Peter H. Howarth Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma Journal of Personalized Medicine breathomics VOC volatile organic compounds repeatability asthma severe asthma |
title | Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma |
title_full | Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma |
title_fullStr | Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma |
title_full_unstemmed | Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma |
title_short | Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma |
title_sort | measurement of exhaled volatile organic compounds as a biomarker for personalised medicine assessment of short term repeatability in severe asthma |
topic | breathomics VOC volatile organic compounds repeatability asthma severe asthma |
url | https://www.mdpi.com/2075-4426/12/10/1635 |
work_keys_str_mv | AT adnanazim measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma AT faisalirezwan measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma AT clairbarber measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma AT matthewharvey measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma AT rameshjkurukulaaratchy measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma AT johnwholloway measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma AT peterhhowarth measurementofexhaledvolatileorganiccompoundsasabiomarkerforpersonalisedmedicineassessmentofshorttermrepeatabilityinsevereasthma |